hologic

Kit consisting primarily of genetic material, oligonucleotides and analogs and derivatives thereof, polynucleotides, nucleotides, standards, chemical or biochemical reagents, diagnostic preparations, buffers and vials for biomedical and scientific research applications and clinical laboratory use (terms considered too vague by the International Bureau - rule 13.2.b) of the Common Regulations); kit consisting primarily of genetic material, oligonucleotides and analogs and derivatives thereof, polynucleotides, nucleotides, standards, chemical or biochemical reagents, diagnostic preparations, buffers and vials for clinical and medical laboratory use (terms considered too vague by the International Bureau - rule 13.2.b) of the Common Regulations). Kit consisting primarily of genetic material, oligonucleotides and analogs and derivatives thereof, polynucleotides, nucleotides, standards, chemical or biochemical reagents, diagnostic preparations, buffers and vials for medical treatment and medical diagnostic purposes (terms considered too vague by the International Bureau - rule 13.2.b) of the Common Regulations); diagnostic test kits comprised of analytes used as markers or indicators for detecting diseases for use in screening women at risk of pre-term delivery and for use in assessing the risk of pre-term delivery and infertility (terms considered too vague by the International Bureau - rule 13.2.b) of the Common Regulations); medical diagnostic reagents; reagents and kits comprising reagents and processing chemicals for use in obstetrics, gynecology and women's health (terms considered too vague by the International Bureau - rule 13.2.b) of the Common Regulations); biossay reagents and kits comprised of bioassay reagents, chemicals and/or solutions for in vitro medical uses in obstetrics, gynecology and women's health, in particular disorders and pre-term birth (terms considered too vague by the International Bureau - rule 13.2.b) of the Common Regulations). Housemark and brand name for laboratory and scientific apparatus and instruments, and parts therefor, all for use in biomedical research, screening for osteoporosis, cervical cancer and breast cancer, namely, photometers, luminometers, assay tube wash stations, laboratory incubators, dry heat baths, assay tube vortex mixers, ultrasonic apparatus for disrupting cells, assay reaction tubes, namely, test tubes and test tube caps, pipettors, pipette tips, pipetting workstations, liquid sample processors for handling liquids, and automated in vitro diagnostic specimen test analyzers comprised of assay processing unit, control unit, and power supply (terms considered too vague by the International Bureau - rule 13.2.b) of the Common Regulations); liquid dispensing bottles, vortexers, sonicators, incubators, dry heat baths, heat block inserts, tubes, reaction vials, tube sealing cards, tube caps, tube racks, specimen racks, magnetic separation system (terms considered too vague by the International Bureau - rule 13.2.b) of the Common Regulations); apparatuses to facilitate the handling of specimens and to facilitate the execution of diagnostic assay procedures, namely pipetters, automated liquid handling systems; kits consisting primarily of laboratory instruments to determine the results of assay procedures (terms considered too vague by the International Bureau - rule 13.2.b) of the Common Regulations). House mark and brand name for medical apparatus and instruments used for the detection, diagnosis, and treatment of breast cancer, namely, breast imaging systems, breast biopsy devices and biopsy image guidance systems, and systems for partial-breast irradiation (terms considered too vague by the International Bureau - rule 13.2.b) of the Common Regulations); house mark and brand name for medical apparatus and instruments used for the detection and diagnosis of osteoporosis, namely, x-ray bone densitometers, x-ray imaging devices, and MRI diagnostic apparatus (terms considered too … (liste kısaltıldı; tamamı TÜRKPATENT kaydında)